Abstract
The full impact of coronavirus disease 2019 (COVID-19) on pregnancy remains uncharacterized. Current literature suggests minimal maternal, fetal, and neonatal morbidity and mortality. COVID-19 manifestations appear similar between pregnant and nonpregnant women. We present a case of placental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in a woman with mild COVID-19 disease, then review the literature. Reverse transcriptase polymerase chain reaction was performed to detect SARS-CoV-2. Immunohistochemistry staining was performed with specific monoclonal antibodies to detect SARS-CoV-2 antigen or to identify trophoblasts. A 29-year-old multigravida presented at 40-4/7 weeks for labor induction. With myalgias 2 days prior, she tested positive for SARS-CoV-2. We demonstrate maternal vascular malperfusion, with no fetal vascular malperfusion, as well as SARS-CoV-2 virus in chorionic villi endothelial cells, and also rarely in trophoblasts. To our knowledge, this is the first report of placental SARS-CoV-2 despite mild COVID-19 disease (no symptoms of COVID-19 aside from myalgias); patient had no fever, cough, or shortness of breath, but only myalgias and sick contacts. Despite her mild COVID-19 disease in pregnancy, we demonstrate placental vasculopathy and presence of SARS-CoV-2 virus across the placenta. Evidence of placental COVID-19 raises concern for placental vasculopathy (potentially leading to fetal growth restriction and other pregnancy complications) and possible vertical transmission-especially for pregnant women who may be exposed to COVID-19 in early pregnancy. This raises important questions of whether future pregnancy guidance should include stricter pandemic precautions, such as screening for a wider array of COVID-19 symptoms, increased antenatal surveillance, and possibly routine COVID-19 testing throughout pregnancy.
Keywords: Coronavirus; SARS coronavirus; public policy.
【저자키워드】 coronavirus, public policy, SARS Coronavirus, 【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, pandemic, Placenta, knowledge, monoclonal antibody, SARS-CoV-2 virus, cough, monoclonal antibodies, virus, COVID-19 disease, pregnant women, polymerase chain reaction, Pregnancy, COVID-19 testing, Reverse transcriptase polymerase chain reaction, Surveillance, endothelial cells, Fever, Patient, Mild, complications, placental, vertical transmission, morbidity and mortality, public policy, women, SARS-CoV-2 antigen, SARS Coronavirus, pregnancy complications, respiratory, COVID-19 symptoms, Guidance, pregnant, manifestation, Neonatal, myalgia, Antenatal, evidence of, reverse transcriptase, Chain Reaction, no symptoms, myalgias, early pregnancy, Shortness of breath, acute respiratory syndrome, Vascular, labor induction, acute respiratory syndrome coronavirus, woman, growth, Mild COVID-19 disease, symptoms of COVID-19, staining, positive, multigravida, precautions, current, polymerase chain, raise, tested, identify, detect, include, was performed, question, sick, had no, fetal, chorionic, nonpregnant, 【제목키워드】 SARS-CoV-2, Pregnant woman, Mild,